A Phase 1b Trial of the Combination of Capecitabine and Erlotinib in Advanced Lung Cancer

被引：0
|
作者：
Kumar, Rajiv [1 ]
Lo, Karl [1 ]
Minchom, Anna R. [1 ]
Sharp, Adam [1 ]
Davidson, Michael [1 ]
Gunapala, Ranga [1 ]
Yap, Timothy [2 ,3 ]
Bhosle, Jaishree [1 ]
Popat, Sanjay [1 ]
O'Brien, Mary E. R. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Dept Lung Med, London, Surrey, England
[2] Inst Canc Res, Dept Lung Med, London, Surrey, England
[3] Royal Marsden NHS Fdn Trust, London, Surrey, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Erlotinib; Capecitabine; Non-small-cell lung cancer; Phase; 1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-077
引用
收藏
页码：S547 / S548
页数：2
相关论文
共 50 条
  • [21] Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial
    Gatzemeier, Ulrich
    Pluzanska, Anna
    Szczesna, Aleksandra
    Kaukel, Eckhard
    Roubec, Jaromir
    De Rosa, Flavio
    Milanowski, Janusz
    Karnicka-Mlodkowski, Hanna
    Pesek, Milos
    Serwatowski, Piotr
    Ramlau, Rodryg
    Janaskova, Terezie
    Vansteenkiste, Johan
    Strausz, Janos
    Manikhas, Georgy Moiseevich
    Von Pawel, Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1545 - 1552
  • [22] Preoperative Radiation Therapy With Concurrent Capecitabine, Bevacizumab, and Erlotinib for Rectal Cancer: A Phase 1 Trial
    Das, Prajnan
    Eng, Cathy
    Rodriguez-Bigas, Miguel A.
    Chang, George J.
    Skibber, John M.
    You, Y. Nancy
    Maru, Dipen M.
    Munsell, Mark F.
    Clemons, Marilyn V.
    Kopetz, Scott E.
    Garrett, Christopher R.
    Shureiqi, Imad
    Delclos, Marc E.
    Krishnan, Sunil
    Crane, Christopher H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 301 - 305
  • [23] Phase 2 small cell lung cancer (SCLC) cohort of a phase 1b/2 trial of a liposomal formulation of eribulin in combination with nivolumab
    Azuma, Koichi
    Murakami, Shuji
    Kawakami, Hisato
    Okishio, Kyoichi
    Tamiya, Motohiro
    Kobayashi, Haruki
    Fujimoto, Daichi
    Sugawara, Shunichi
    Kozuki, Toshiyuki
    Oya, Yuko
    Izumi, Hiroki
    Shiroyama, Takayuki
    Tohnai, Rie
    Yamamoto, Noboru
    Kaname, Shota
    Matsuoka, Daiko
    Otake, Yohei
    Takase, Takao
    Semba, Taro
    Nishio, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction
    Maarten J. Deenen
    Didier Meulendijks
    Henk Boot
    Marie-Cecile J. C. Legdeur
    Jos H. Beijnen
    Jan H. M. Schellens
    Annemieke Cats
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1285 - 1295
  • [25] Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction
    Deenen, Maarten J.
    Meulendijks, Didier
    Boot, Henk
    Legdeur, Marie-Cecile J. C.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Cats, Annemieke
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1285 - 1295
  • [26] Phase 1b/2 trial of HER3 inhibitor U3-1287 in combination with erlotinib in advanced NSCLC patients (pts): HERALD study
    von Pawel, Joachim
    Lueps, Barbara
    Tseng, Jennifer
    Copigneaux, Catherine
    Beckmann, Robert
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [27] Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer
    Shatsky, Rebecca A.
    Schwab, Richard B.
    Helsten, Teresa L.
    Pittman, Emily I.
    Chen, Ruifeng
    Breitmeyer, James B.
    Jamieson, Catriona H. M.
    Kipps, Thomas J.
    Parker, Barbara A.
    CANCER RESEARCH, 2020, 80 (04)
  • [28] Phase I trial of vorinostat in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations after erlotinib progression
    Reguart, N.
    Cardona, A. F.
    Isla, D.
    Cardenal, F.
    Palmero, R.
    Carrasco-Chaumel, E.
    Rolfo, C.
    Massuti, B.
    Moran, T.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] A PHASE 1B STUDY OF AMG 655 IN COMBINATION WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Paz-Ares, L.
    Torres, J. M. Sanchez
    Diaz-Padilla, I.
    Links, M.
    Reguart, N.
    Boyer, M.
    Wiezorek, J.
    Sabin, T.
    Hsu, M.
    Van Meerbeeck, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 161 - 161
  • [30] A phase 1b dose escalation trial of gemcitabine and nab-paclitaxel in combination with lixumistat in patients with advanced pancreatic cancer.
    Pant, Shubham
    Smaglo, Brandon George
    Huey, Ryan W.
    Haldar, Saurav Daniel
    Morelli, Maria Pia
    Willis, Jason
    Xiao, Lianchun
    Yuan, Ying
    Attanasio, Sergio
    Shah, Rutvi
    Citron, Francesca
    Zhao, Dan
    Kopetz, Scott
    Maitra, Anirban
    Welsch, Dean
    Sheth, Rahul
    Bhosale, Priya
    Wolff, Robert A.
    Viale, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 743 - 743
12345